Marissa Shapiro

Crucial research by Neil Osheroff and his lab leads to approval of the first new class of antibacterial drugs in decades. Read More

“Logan is a role model for scientists at all levels,” said Julie Rhoades, professor of medicine and associate professor of biomedical engineering. “His positivity, patience and passion for mentoring and science is exceptional. He was willing to step out of his science comfort zone and tackle challenging projects, and he is also one of the nicest people I have ever met. We miss his presence in the lab.” Read More

The meeting on March 6 convened researchers from the Vanderbilt School of Medicine Basic Sciences focused on pharmacology, molecular physiology, and protein dynamics and biochemistry, alongside ORNL scientists engaged in exascale artificial intelligence, microbial science, molecular biophysics, neutron science, advanced mass spectrometry, and medical isotopes research and development. Read More

Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics, has been named senior associate dean for research for the School of Medicine Basic Sciences. He succeeds Chuck Sanders, who will transition from vice dean to a new role as senior advisor to the dean, effective July… Read More

Over the past few months, the federal research funding landscape has begun to shift. As a response to some of the transitions taking place, Vanderbilt University is launching the Provost Discovery Bridge Funding Program. This program will provide short-term financial support ranging from three to six months to faculty researchers affected by changes in federal policy. Read More

Since its February 2025 publication in Nature Cell Biology, a groundbreaking study from the Burnette Lab has drawn more than 44,000 Article Accesses—amplified by Vanderbilt’s new open access agreement with Springer Nature. The study reveals the existence of blebbisomes, massive, motile extracellular vesicles that behave almost like mini cells. Packed with organelles and capable of delivering immune-modulating proteins, blebbisomes may one day serve as therapeutic couriers or targets in cancer treatment. Read More

Lisa M. Monteggia and Matthew J. Tyska are among the 471 scientists elected as 2024 fellows of the American Association for the Advancement of Science. Dean John Kuriyan was also recently elected a member of the 2025 class of fellows of the American Association for Cancer Research academy. Read More

2024–25 Global Engagement Funding proposals are due by May 5, 2025. Read More

“This transformative agreement allows Vanderbilt researchers to benefit from Nature’s tremendous influence and reach,” University Librarian Jon Shaw said. “Our research findings will reach global audiences immediately upon publication, speeding up scientific innovation and progress. This collaboration not only strengthens Vanderbilt’s reputation but will aid in attracting top faculty, students and partnerships to the university.” Read More

Vanderbilt-affiliated authors may publish their original research articles APC-free in JAMA Network journals through a Creative Commons license. Twelve of the network’s journals—including JAMA Internal Medicine, JAMA Neurology and JAMA Oncology—are ranked in the top quartile of their respective subject areas. Read More